Cramer was bearish on Linn Energy ( LINE).

Executive Decision: Ron Squarer

In the "Executive Decision" segment, Cramer sat down with Ron Squarer, CEO of Array BioPharma ( ARRY), another speculative biotech company fighting the war against cancer. Shares of Array are up 64% so far in 2013.

Squarer said one of the big reasons for his company's success has been having great partners. He said Array has partnered with a number of big names in the industry and has learned a lot while helping to bring many new exciting treatments to fruition. That said, Squarer also said any biotech's success comes down to two things: good science and excellent decisions, both of which Array has been fortunate to have in recent years.

Squarer highlighted a few projects, including a partnership with Onyx Pharmaceuticals ( ONXX) for a drug they call "520." He said there should be news out by the end of the year for this blood cancer treatment. Also on the horizon, 502, the company's asthma treatment, which is potentially the first major advance in 15 years in that area.

Cramer said that like Pharmacyclics, Array is another great speculative way to play the many advances that are being made in the fight against cancer.

Mad Tweets

In his "Mad Tweets" segment, Cramer followed up on a few stocks that stumped him during earlier shows. He said Nektar Threrapeutics ( NKTR), which saw its shares plummet 24% today after one of its drugs failed to make the grade, should be held until the company's analyst day on Oct. 8.

Cramer said that all the good news is already baked into the stock of GT Advanced Technologies ( GTAT), and he'd wait for a pullback before considering it.

Turning to two IPOs from May, Cramer said Insys Therapeutics ( INSY) may have already risen 320% for the year but it remains reasonably valued. He was not impressed with Cyan ( CYNI), which missed its first quarter as a public company.

When asked about International Paper ( IP), Cramer said a recent downgrade was wrong. He was less enthusiastic about Westport Innovations ( WPRT), saying that while he still likes the story, the company needs a lot more financing.

Finally, Cramer said that he's still bullish on GameStop ( GME) ahead of the new game cycle and would buy shares on any weakness.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
At the time of publication, Cramer's Action Alerts PLUS had a position in JNJ and LINE.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

If you liked this article you might like

Stocks Eclipsed by Nothing: Cramer's 'Mad Money' Recap (Monday 8/21/17)

Jim Cramer -- It's Time to Get to the Bottom of ADP

Chipotle-Loving Bill Ackman Locked and Loaded to Torch ADP

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Mixed Signals Perplex Markets: Cramer's 'Mad Money' Recap (Friday 6/23/17)